AI-based Anomaly Detection for Clinical-Grade Histopathological Diagnostics
0
Sign in to get full access
Overview
• This paper presents an AI-based anomaly detection system for clinical-grade histopathological diagnostics, which can help improve the accuracy and consistency of medical diagnoses made from microscopic tissue samples.
• The system uses deep learning models to analyze digital images of tissue samples and identify abnormalities or anomalies that may be indicative of disease.
• By automating the process of identifying and flagging potential issues, the system has the potential to assist pathologists in making more reliable and timely diagnoses, ultimately leading to better patient outcomes.
Plain English Explanation
When doctors need to diagnose a patient's medical condition, they often examine tissue samples under a microscope. This process, known as histopathological analysis, requires highly trained experts called pathologists to carefully inspect the tissue and identify any abnormalities that could be a sign of disease.
However, this manual inspection can be time-consuming and subjective, as different pathologists may interpret the same tissue sample differently. To address this challenge, the researchers in this paper developed an AI-based system that can automatically detect anomalies in digital images of tissue samples.
The system uses advanced machine learning algorithms, specifically deep learning models, to analyze the complex patterns and structures within the tissue images. By training the models on a large dataset of both normal and abnormal tissue samples, the system can learn to recognize the visual characteristics of various diseases and identify any deviations from the expected patterns.
Once the system is deployed, it can rapidly analyze new tissue samples and flag any potential anomalies for the pathologist to review. This can help streamline the diagnostic process, reduce the risk of human error, and ensure more consistent and reliable diagnoses across different healthcare providers.
Ultimately, the goal of this AI-based system is to enhance the accuracy and efficiency of clinical-grade histopathological diagnostics, leading to improved patient care and outcomes. By leveraging the power of machine learning, the researchers aim to support and empower pathologists in their critical role of identifying and diagnosing various medical conditions.
Technical Explanation
• The paper presents a novel AI-based system for automated anomaly detection in histopathological images, which can aid in clinical-grade diagnostic decision-making.
• The system employs deep learning models, specifically convolutional neural networks (CNNs), to analyze high-resolution digital images of tissue samples and identify any abnormalities or anomalies that may be indicative of disease.
• The researchers trained their models on a large, curated dataset of histopathological images, including both normal and diseased tissue samples, to enable the system to learn the visual characteristics of various pathological conditions.
• The trained models are then used to process new tissue sample images, with the system flagging any detected anomalies for further review by pathologists. This can help streamline the diagnostic process and improve the consistency and reliability of clinical-grade histopathological assessments.
• The paper also discusses the importance of interpretability and explainability in the AI system, as well as the need for rigorous validation and testing to ensure the system's performance meets the stringent requirements of clinical-grade diagnostics.
• The researchers highlight the potential of this AI-based anomaly detection system to enhance the accuracy and efficiency of histopathological diagnostics, ultimately leading to better patient outcomes.
Critical Analysis
• While the proposed AI-based system shows promise in improving the efficiency and consistency of histopathological diagnostics, the paper acknowledges the need for further validation and testing to ensure the system's reliability and robustness in real-world clinical settings.
• The researchers emphasize the importance of maintaining human oversight and involvement in the diagnostic process, as the AI system should be designed to complement and support pathologists, rather than replace them entirely.
• Potential challenges and limitations include the need for large, diverse, and high-quality training data to ensure the AI models can generalize to a wide range of pathological conditions, as well as the inherent complexity and variability of histopathological samples.
• Additionally, the paper highlights the ongoing need for improved interpretability and explainability of the AI system's decision-making process, to foster trust and enable pathologists to understand the rationale behind the system's anomaly detection.
• Future research directions may include exploring the integration of this AI-based system with other diagnostic modalities, such as Exploring Explainable AI Techniques for Improved Interpretability in Lung Disease Detection or Artificial Intelligence for Abnormality Detection in High-Volume Neuroimaging, to provide a more comprehensive and robust diagnostic framework.
Conclusion
• The paper presents a promising AI-based anomaly detection system for clinical-grade histopathological diagnostics, which has the potential to enhance the accuracy, consistency, and efficiency of medical diagnoses made from microscopic tissue samples.
• By leveraging deep learning models to automatically analyze digital tissue images and identify potential abnormalities, the system can support pathologists in their critical role, ultimately leading to improved patient outcomes.
• While the research demonstrates the viability of this AI-based approach, ongoing validation, testing, and refinement will be necessary to ensure the system meets the stringent requirements of clinical-grade diagnostics and maintains a strong partnership between the AI and human experts.
• As the field of AI-based Pathology Diagnostics continues to evolve, this work represents an important step towards leveraging the power of machine learning to enhance the quality and efficiency of medical diagnostics.
This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!
Related Papers
0
AI-based Anomaly Detection for Clinical-Grade Histopathological Diagnostics
Jonas Dippel, Niklas Preni{ss}l, Julius Hense, Philipp Liznerski, Tobias Winterhoff, Simon Schallenberg, Marius Kloft, Oliver Buchstab, David Horst, Maximilian Alber, Lukas Ruff, Klaus-Robert Muller, Frederick Klauschen
While previous studies have demonstrated the potential of AI to diagnose diseases in imaging data, clinical implementation is still lagging behind. This is partly because AI models require training with large numbers of examples only available for common diseases. In clinical reality, however, only few diseases are common, whereas the majority of diseases are less frequent (long-tail distribution). Current AI models overlook or misclassify these diseases. We propose a deep anomaly detection approach that only requires training data from common diseases to detect also all less frequent diseases. We collected two large real-world datasets of gastrointestinal biopsies, which are prototypical of the problem. Herein, the ten most common findings account for approximately 90% of cases, whereas the remaining 10% contained 56 disease entities, including many cancers. 17 million histological images from 5,423 cases were used for training and evaluation. Without any specific training for the diseases, our best-performing model reliably detected a broad spectrum of infrequent (anomalous) pathologies with 95.0% (stomach) and 91.0% (colon) AUROC and generalized across scanners and hospitals. By design, the proposed anomaly detection can be expected to detect any pathological alteration in the diagnostic tail of gastrointestinal biopsies, including rare primary or metastatic cancers. This study establishes the first effective clinical application of AI-based anomaly detection in histopathology that can flag anomalous cases, facilitate case prioritization, reduce missed diagnoses and enhance the general safety of AI models, thereby driving AI adoption and automation in routine diagnostics and beyond.
Read more6/24/2024
🗣️
0
Applications of artificial intelligence in the analysis of histopathology images of gliomas: a review
Jan-Philipp Redlich, Friedrich Feuerhake, Joachim Weis, Nadine S. Schaadt, Sarah Teuber-Hanselmann, Christoph Buck, Sabine Luttmann, Andrea Eberle, Stefan Nikolin, Arno Appenzeller, Andreas Portmann, Andr'e Homeyer
In recent years, the diagnosis of gliomas has become increasingly complex. Analysis of glioma histopathology images using artificial intelligence (AI) offers new opportunities to support diagnosis and outcome prediction. To give an overview of the current state of research, this review examines 83 publicly available research studies that have proposed AI-based methods for whole-slide histopathology images of human gliomas, covering the diagnostic tasks of subtyping (23/83), grading (27/83), molecular marker prediction (20/83), and survival prediction (29/83). All studies were reviewed with regard to methodological aspects as well as clinical applicability. It was found that the focus of current research is the assessment of hematoxylin and eosin-stained tissue sections of adult-type diffuse gliomas. The majority of studies (52/83) are based on the publicly available glioblastoma and low-grade glioma datasets from The Cancer Genome Atlas (TCGA) and only a few studies employed other datasets in isolation (16/83) or in addition to the TCGA datasets (15/83). Current approaches mostly rely on convolutional neural networks (63/83) for analyzing tissue at 20x magnification (35/83). A new field of research is the integration of clinical data, omics data, or magnetic resonance imaging (29/83). So far, AI-based methods have achieved promising results, but are not yet used in real clinical settings. Future work should focus on the independent validation of methods on larger, multi-site datasets with high-quality and up-to-date clinical and molecular pathology annotations to demonstrate routine applicability.
Read more7/15/2024
🔮
0
Pathology Foundation Models
Mieko Ochi, Daisuke Komura, Shumpei Ishikawa
Pathology has played a crucial role in the diagnosis and evaluation of patient tissue samples obtained from surgeries and biopsies for many years. The advent of Whole Slide Scanners and the development of deep learning technologies have significantly advanced the field, leading to extensive research and development in pathology AI (Artificial Intelligence). These advancements have contributed to reducing the workload of pathologists and supporting decision-making in treatment plans. Recently, large-scale AI models known as Foundation Models (FMs), which are more accurate and applicable to a wide range of tasks compared to traditional AI, have emerged, and expanded their application scope in the healthcare field. Numerous FMs have been developed in pathology, and there are reported cases of their application in various tasks, such as disease diagnosis, rare cancer diagnosis, patient survival prognosis prediction, biomarker expression prediction, and the scoring of immunohistochemical expression intensity. However, several challenges remain for the clinical application of FMs, which healthcare professionals, as users, must be aware of. Research is ongoing to address these challenges. In the future, it is expected that the development of Generalist Medical AI, which integrates pathology FMs with FMs from other medical domains, will progress, leading to the effective utilization of AI in real clinical settings to promote precision and personalized medicine.
Read more8/7/2024
0
Exploring Explainable AI Techniques for Improved Interpretability in Lung and Colon Cancer Classification
Mukaffi Bin Moin, Fatema Tuj Johora Faria, Swarnajit Saha, Busra Kamal Rafa, Mohammad Shafiul Alam
Lung and colon cancer are serious worldwide health challenges that require early and precise identification to reduce mortality risks. However, diagnosis, which is mostly dependent on histopathologists' competence, presents difficulties and hazards when expertise is insufficient. While diagnostic methods like imaging and blood markers contribute to early detection, histopathology remains the gold standard, although time-consuming and vulnerable to inter-observer mistakes. Limited access to high-end technology further limits patients' ability to receive immediate medical care and diagnosis. Recent advances in deep learning have generated interest in its application to medical imaging analysis, specifically the use of histopathological images to diagnose lung and colon cancer. The goal of this investigation is to use and adapt existing pre-trained CNN-based models, such as Xception, DenseNet201, ResNet101, InceptionV3, DenseNet121, DenseNet169, ResNet152, and InceptionResNetV2, to enhance classification through better augmentation strategies. The results show tremendous progress, with all eight models reaching impressive accuracy ranging from 97% to 99%. Furthermore, attention visualization techniques such as GradCAM, GradCAM++, ScoreCAM, Faster Score-CAM, and LayerCAM, as well as Vanilla Saliency and SmoothGrad, are used to provide insights into the models' classification decisions, thereby improving interpretability and understanding of malignant and benign image classification.
Read more5/15/2024